Denali Therapeutics Inc. buy melinda
Start price
16.03.20
/
50%
€12.22
Target price
04.11.21
€55.00
Performance (%)
269.76%
End price
05.11.21
€45.17
Summary
This prediction ended on 05.11.21 with a price of €45.17. With a performance of 269.76% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Denali Therapeutics Inc. | 11.124% | 11.124% | -35.409% | -58.651% |
| iShares Core DAX® | -0.383% | 5.404% | 14.198% | 21.243% |
| iShares Nasdaq 100 | 1.248% | 6.732% | 34.022% | 59.234% |
| iShares Nikkei 225® | 0.525% | 1.840% | 10.062% | 9.459% |
| iShares S&P 500 | 0.640% | 4.710% | 27.309% | 50.394% |
According to melinda what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Denali Therapeutics Inc. diskutieren
Buy mit Kursziel 20,0
Kursziel geändert auf 55,0
In the thread Trading Denali Therapeutics Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten